» Articles » PMID: 32095621

Surgical Treatment Strategies for Hepatic Alveolar Echinococcosis

Overview
Date 2020 Feb 26
PMID 32095621
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Alveolar echinococcosis is a severe and rare helminthic disease with increasing incidence in endemic regions. Herein, available evidence on curative surgical and potential palliative approaches was reviewed. Such strategies have to be applied in the context of available resources in different health-care systems. Complete resection followed by adjuvant therapy remains the only curative treatment available. Curative surgery is performed by open or laparoscopic approach depending on the extent of the disease and the experience of the surgical team. Palliative resections are typically not indicated, because the availability of endoscopic treatments of biliary complications and long-term benzimidazoles represent efficient alternatives to surgery. Liver transplantation as an alternative to palliative surgery has not been shown to be superior to long-term conservative therapy. Immunosuppressive therapy might additionally contribute to fatal disease recurrence after transplantation.

Citing Articles

A Case Series and Literature Review of Alveolar Echinococcosis in Kashmir, India: An Emerging Endemic Zone for .

Khuroo M, Khuroo N, Rather A Life (Basel). 2024; 14(7).

PMID: 39063549 PMC: 11277966. DOI: 10.3390/life14070794.


Liver autotransplantation and atrial reconstruction on a patient with multiorgan alveolar echinococcosis: a case report.

Ruze R, Jiang T, Zhang W, Zhang M, Zhang R, Guo Q BMC Infect Dis. 2024; 24(1):659.

PMID: 38956482 PMC: 11218102. DOI: 10.1186/s12879-024-09545-0.


Applying LASSO logistic regression for the prediction of biliary complications after ex vivo liver resection and autotransplantation in patients with end-stage hepatic alveolar echinococcosis.

Lin X, Shao Y, Zhang R, Aji T Eur J Med Res. 2024; 29(1):301.

PMID: 38812045 PMC: 11134669. DOI: 10.1186/s40001-024-01898-1.


Phenotype and function of MAIT cells in patients with alveolar echinococcosis.

Li J, Zhao H, Lv G, Aimulajiang K, Li L, Lin R Front Immunol. 2024; 15:1343567.

PMID: 38550591 PMC: 10973110. DOI: 10.3389/fimmu.2024.1343567.


Percutaneous management in hepatic alveolar echinococcosis: A sum of single center experiences and a brief overview of the literature.

Eren S, Aydin S, Kantarci M, Kizilgoz V, Levent A, Senbil D World J Gastrointest Surg. 2023; 15(3):398-407.

PMID: 37032805 PMC: 10080597. DOI: 10.4240/wjgs.v15.i3.398.


References
1.
Du C, Liu Z, Yang X, Yan L, Li B, Wen T . Hepatectomy for patients with alveolar echinococcosis: Long-term follow-up observations of 144 cases. Int J Surg. 2016; 35:147-152. DOI: 10.1016/j.ijsu.2016.09.094. View

2.
Joliat G, Melloul E, Petermann D, Demartines N, Gillet M, Uldry E . Outcomes After Liver Resection for Hepatic Alveolar Echinococcosis: A Single-Center Cohort Study. World J Surg. 2015; 39(10):2529-34. DOI: 10.1007/s00268-015-3109-2. View

3.
Bresson-Hadni S, Delabrousse E, Blagosklonov O, Bartholomot B, Koch S, Miguet J . Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis. Parasitol Int. 2006; 55 Suppl:S267-72. DOI: 10.1016/j.parint.2005.11.053. View

4.
Li S, Huang T, Shen S, Hua Y, Hu W, Kuang M . Anatomical versus non-anatomical liver resection for hepatocellular carcinoma exceeding Milan criteria. Br J Surg. 2016; 104(1):118-127. DOI: 10.1002/bjs.10311. View

5.
Koch S, Bresson-Hadni S, Miguet J, Crumbach J, Gillet M, Mantion G . Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report. Transplantation. 2003; 75(6):856-63. DOI: 10.1097/01.TP.0000054230.63568.79. View